New therapeutic approaches to the alphaherpesvirus infections

被引:70
作者
Cassady, KA
Whitley, RJ
机构
[1] Ambulatory Care Center, Children's Hospital of Alabama, Birmingham, AL 35222
关键词
D O I
10.1093/jac/39.2.119
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The character of diseases caused by alphaherpesviruses has changed over the last decade. The severity of disease and the frequency of acyclovir resistance has increased with the increase in the number of immunocompromised patients. Compounding the trend towards more virulent herpes disease is the current emphasis towards outpatient management of many diseases. Much of the current antiviral research focuses on providing drugs with (i) improved oral bioavailability and pharmacokinetics which permit less frequent oral or topical dosing for suppressive treatment of herpes simplex virus (HSV) infections, (ii) different mechanisms of action for synergic effects in treating resistant HSV infections in the immunocompromised host and (iii) improved efficacy. Future antiviral agents will probably target enzymes or viral factors essential for infection or will inhibit other steps in the viral infection cycle, such as viral entry, protein synthesis or capsid assembly. Medications that augment the immune response constitute another pathway for combating herpes viral infections. Many of the newer experimental agents target essential processes unique to herpesvirus replication and, therefore, potentially have high selectivity.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 77 条
  • [21] VARICELLA VACCINE - THE AMERICAN EXPERIENCE
    GERSHON, AA
    LARUSSA, P
    HARDY, I
    STEINBERG, S
    SILVERSTEIN, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 : S63 - S68
  • [22] GERSHON AA, 1991, REV INFECT DIS, V13, pS957
  • [23] NEW ANTIVIRALS WITH ACTIVITY AGAINST VARICELLA-ZOSTER VIRUS
    GNANN, JW
    [J]. ANNALS OF NEUROLOGY, 1994, 35 : S69 - S72
  • [24] GORDON YJ, 1994, CORNEA, V13, P516
  • [25] HALL CB, 1995, PEDIATRICS, V95, P791
  • [26] HARRISON CJ, 1995, ANTIVIR RES, V26, pA233
  • [27] VIRUSES AS TOOLS IN DRUG DELIVERY
    HELENIUS, A
    DOXSEY, S
    MELLMAN, I
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 : 1 - 6
  • [28] Hitchcock MJM, 1995, ANTIVIR RES, V26, pA358, DOI 10.1016/0166-3542(95)94952-X
  • [29] IMBERTSON LM, 1995, ANTIVIR RES, V26, pA301
  • [30] JACOBSON MA, 1993, J MED VIROL, P150